FerriScan: Information for Clinicians

FerriScan is being used by clinicians in over 20 countries worldwide to aid their diagnosis, management and monitoring of iron overload.

It is a tool of proven value in improving the health outcomes of patients suffering from diseases such as thalassaemia, sickle cell disease, haemochromatosis and myelodysplastic syndrome.

The use of FerriScan has been included in case study data from international centres of excellence.

Thalassaemia Case Study

Sickle Cell Disease Case Study

Haemochromatosis Case Study

FerriScan provides the clinician with:

• A baseline measurement of the precise concentration and distribution of iron in the liver.
• Assistance in acquiring a definitive iron overload diagnosis
• The ability to achieve an optimised treatment, matched to the exact level of iron loading

FerriScan is now also being included in the iron overload management protocols of leading physicians.

Myelodysplastic Syndrome Protocol

Information about iron overload and evidence for the use of FerriScan in its management is included in the following presentations.

Transfusional iron overload presentation

Hereditary Haemochromatosis presentation

As a quality controlled company, Resonance Health has developed a reputation for the highest standards of scientific rigour.

FerriScan has been validated by international regulatory authorities and is widely used by major pharmaceutical companies in clinical trial settings.

Many scientific publications have provided evidence for the use of FerriScan in clinical management of iron overload conditions.

Recent Studies using FerriScan for iron quantification

Blood paper 2005